Seven Springs Wealth Group’s AbbVie ABBV Stock Holding History

Seven Springs Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,154	Closed	-$448K	–	65
2021 Q3	$448K	Hold	4,154	–	–	0.22%	42
2021 Q2	$468K	Buy	4,154 +3,737	+896%	+$421K	0.2%	45
2021 Q1	$45K	Sell	417 -65	-13%	-$6.95K	0.02%	84
2020 Q4	$52K	Buy	482 +65	+16%	+$6.25K	0.03%	76
2020 Q3	$37K	Hold	417	–	–	0.02%	79
2020 Q2	$41K	Hold	417	–	–	0.03%	75
2020 Q1	$32K	Hold	417	–	–	0.02%	79
2019 Q4	$37K	Buy	+417	New	+$34.6K	0.03%	101

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Seven Springs Wealth Group's ABBV Position: Q4 2021 in Review

Seven Springs Wealth Group sold out of AbbVie (ABBV) in Q4 2021, closing a stake of 4,154 shares — an estimated $448K sold.

Seven Springs Wealth Group first reported a position in ABBV in Q4 2019 and held it in 8 quarters. The position peaked at $468K in Q2 2021. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

Seven Springs Wealth Group reported no remaining AbbVie position as of Q4 2021 after selling out during the quarter.
Seven Springs Wealth Group sold 4,154 AbbVie shares in Q4 2021, an estimated $448K.
Seven Springs Wealth Group first reported a position in AbbVie in Q4 2019 and held it in 8 quarters.
Seven Springs Wealth Group's AbbVie position peaked at $468K in Q2 2021.
2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Seven Springs Wealth Group's 13F filing for Q4 2021, filed 4 Feb 2022.